Integer Holdings Corporation
General ticker "ITGR" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $3.2B (TTM average)
Integer Holdings Corporation does not follow the US Stock Market performance with the rate: -6.1%.
Estimated limits based on current volatility of 1.9%: low 94.57$, high 98.32$
Factors to consider:
- Total employees count: 11000 (0.0%) as of 2025
- US accounted for 54.7% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Customer concentration, Supply chain disruptions, Raw material costs, Operational and conduct risks, Cybersecurity threats
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [57.18$, 94.96$]
- 2026-12-31 to 2027-12-31 estimated range: [55.18$, 90.38$]
Financial Metrics affecting the ITGR estimates:
- Negative: with PPE of 12.2 at the end of fiscal year the price was high
- Positive: 6.62 < Operating cash flow per share per price, % of 7.23
- Positive: 7.57 < Operating profit margin, % of 11.94
- Positive: 42.57 < Shareholder equity ratio, % of 51.21 <= 64.23
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -0.56 <= 0
- Negative: Investing cash flow per share per price, % of -9.98 <= -4.39
Short-term ITGR quotes
Long-term ITGR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,555.66MM | $1,716.60MM | $1,853.64MM |
| Operating Expenses | $1,392.33MM | $1,508.36MM | $1,632.37MM |
| Operating Income | $163.32MM | $208.24MM | $221.26MM |
| Non-Operating Income | $-57.94MM | $-60.67MM | $-95.87MM |
| Interest Expense | $51.27MM | $56.37MM | $43.21MM |
| R&D Expense | $61.97MM | $53.42MM | $49.50MM |
| Income(Loss) | $105.38MM | $147.56MM | $125.40MM |
| Taxes | $16.24MM | $26.51MM | $22.57MM |
| Other Income(Loss) | $1.51MM | $-1.16MM | $-0.02MM |
| Net Income(Loss)* | $90.65MM | $121.05MM | $102.81MM |
| Stockholders Equity | $1,519.04MM | $1,619.21MM | $1,746.64MM |
| Inventory | $229.10MM | $247.13MM | $253.74MM |
| Assets | $2,942.65MM | $3,077.97MM | $3,410.58MM |
| Operating Cash Flow | $180.21MM | $205.21MM | $196.15MM |
| Capital expenditure | $119.94MM | $105.36MM | $91.03MM |
| Investing Cash Flow | $-163.37MM | $-195.41MM | $-270.73MM |
| Financing Cash Flow | $-18.01MM | $13.32MM | $43.56MM |
| Earnings Per Share** | $2.72 | $3.60 | $2.96 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.